查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
迷幻药市场，按药物类型、按应用、分销管道、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1351417

迷幻药市场，按药物类型、按应用、分销管道、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Psychedelic Drugs Market, by Drug Type, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 311 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022年迷幻药市场规模为48.7012亿美元，2023年至2030年复合年增长率为13.46%。

虽然这些化学製剂因其潜在的治疗和精神应用而引起了科学界的关注，但它们的使用存在固有的风险。这些危害包括个人在接触这些物质时可能遇到的不良副作用和心理挑战。

迷幻药市场 - 市场动态：

  • 提高人们对解决心理健康问题重要性的认识
  • 市场的成长很大程度上取决于对解决城市拥挤和交通效率低下挑战的解决方案的需求。新兴技术和创新的出行解决方案在重新定义城市交通景观方面发挥关键作用，为缓解交通拥堵和减少环境影响提供了新颖的方法。在整个预测期内，预计促进永续城市交通的政府措施、公私合作和宣传活动将推动市场扩张。
  • 例如，近几十年来，城市交通基金会等组织率先发起了旨在改变城市交通模式的措施。他们的努力促成了永续交通实践的开发和采用，为更有效率、更环保的城市通勤选择做出了贡献。

迷幻药市场 - 主要见解：

  • 根据我们的研究分析师提供的见解，全球迷幻药物市场将经历强劲的年增长率，预计 2023 年至 2030 年的预测期内复合年增长率 (CAGR) 约为 14.2%。
  • 该行业的成长轨迹受到重要因素的支撑，主要是人们越来越认识到在全球范围内解决心理健康挑战的迫切需求。
  • 在药物分类领域，裸盖菇素细分市场在 2022 年的市场份额方面占据主导地位。
  • 此外，在考虑应用细分时，与难治性忧郁症治疗相关的类别在 2022 年脱颖而出，成为领跑者。
  • 从分销管道来看，2022年医院在市场占有率方面处于领先地位。
  • 从地域角度来看，北美地区将成为 2022 年的主要收入来源。

迷幻药市场-細項分析：

  • 全球迷幻药市场呈现全面的细分结构，以药物类型、应用、技术和地理区域作为主要分类。
  • 在药物类型分类范围内，市场呈现多种类别，包括氯胺酮、γ-羟基丁酸(GHB)、麦角酸二乙酰胺(LSD)、赛洛西宾、3,4-甲基烯二氧基甲基安非他命和各种其他药物类型。值得注意的是，目前市场格局由裸盖菇素主导。这种特殊的化合物一直处于临床研究的前沿，研究重点是其治疗成瘾、焦虑、忧郁和临终痛苦等一系列疾病的潜在功效。初步研究结果揭示了有希望的结果，激发了人们对基于裸盖菇素的治疗方式的开发的极大兴趣和财政支持。

迷幻药市场-竞争格局：

企业采用多种策略将产品推向市场，利用一系列分销管道，如企业网站、线上零售平台、实体零售商、分销​​合作伙伴和直接面向消费者的模式。产品製造商在定价策略、产品性能、製造技术、技术创新、品牌声誉和产品可用性等多个方面竞争。

为了巩固市场地位并扩大市场份额，公司采用了一系列策略。其中包括透过新产品发布增强产品组合、扩大分销网络、增加研发投资以及参与併购。

例如，2022 年 10 月，Numinus Wellness Inc.（一家致力于推进实证安全迷幻辅助治疗的精神保健组织）推出了氯胺酮治疗严重和慢性疾病计划。这项创新措施预计将首先在位于不列颠哥伦比亚省、犹他州和魁北克省的 Numinus 诊所推出，这标誌着透过新颖的治疗途径解决医疗问题的渐进方法。

目录

第一章：迷幻药市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按药物类型分類的迷幻药物市场片段
    • 迷幻药市场片段（按应用）
    • 迷幻药市场片段（依分布）
    • 按国家/地区分類的迷幻药物市场片段
    • 按地区分類的迷幻药市场片段
  • 竞争洞察

第 3 章：迷幻药主要市场趋势

  • 迷幻药市场驱动因素
    • 市场驱动因素的影响分析
  • 迷幻药市场限制
    • 市场限制影响分析
  • 迷幻药市场机会
  • 迷幻药市场未来趋势

第 4 章：迷幻药物产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：迷幻药市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：迷幻药市场格局

  • 2022 年迷幻药市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：迷幻药市场 - 依药物类型

  • 概述
    • 按药物类型分類的细分市场份额分析
    • 氯胺酮
    • γ-羟基丁酸 (GHB)
    • 麦角酸二乙酰胺 (LSD)
    • 裸盖菇素
    • 3,4-甲基烯二氧基甲基苯丙胺
    • 其他药物类型

第 8 章：迷幻药市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 阿片成瘾
    • 难治性忧郁症
    • 发作性睡病
    • 创伤后压力症候群
    • 恐慌症
    • 其他应用

第 9 章：迷幻药市场 - 按分布

  • 概述
    • 按分布分類的细分市场占有率分析
    • 零售药房
    • 医院药房
    • 线上分销通路

第 10 章：迷幻药市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美迷幻药主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按药物类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按分布）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲迷幻药主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按药物类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模与预测（按分布）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区迷幻药主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模和预测（按药物类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模与预测（按分布）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲迷幻药主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按药物类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模与预测（按分布）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲迷幻药主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按药物类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（按分布）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 迷幻药物产业

  • 竞争仪表板
  • 公司简介
    • Silo Wellness
    • Revive Therapeutics
    • PsyBio Therapeutics
    • Numinus Wellness
    • Mydecine Innovations Group
    • MindMed
    • MagicMed Industries
    • Field Trip Health
    • Entheon Biomedical
    • Eleusis Ltd.
    • Cybin Inc.
    • Compass Pathways
    • Bright Minds Biosciences
    • Beckley Psytech
    • Atai Life Sciences

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1666

REPORT HIGHLIGHT

Psychedelic Drugs Market size was valued at USD 4,870.12 Million in 2022, expanding at a CAGR of 13.46% from 2023 to 2030.

Substances categorized as "psychedelics" possess the capacity to induce profound alterations in perception, cognitive processes, and emotional states, often leading to intense sensory encounters and potentially life-altering insights. This category includes substances like psilocybin mushrooms, DMT (dimethyltryptamine), and LSD (lysergic acid diethylamide). These compounds exert their effects by targeting specific receptors in the brain, resulting in hallucinogenic phenomena, heightened emotional responses, and shifts in consciousness.

While these chemical agents have garnered scientific attention for their potential therapeutic and spiritual applications, their usage carries inherent risks. These hazards encompass adverse side effects and psychological challenges that individuals may encounter when engaging with these substances.

Psychedelic Drugs Market - Market Dynamics:

  • Increasing awareness about the importance of addressing mental health concerns
  • The growth of the market is significantly shaped by the demand for solutions addressing the challenges of urban congestion and transportation inefficiencies. Emerging technologies and innovative mobility solutions are playing a pivotal role in redefining urban transportation landscapes, offering novel approaches to alleviate traffic congestion and reduce environmental impact. Throughout the forecasted period, it is anticipated that government initiatives, public-private collaborations, and advocacy campaigns promoting sustainable urban mobility will drive market expansion.
  • For example, in recent decades, organizations like the Urban Mobility Foundation have spearheaded initiatives aimed at transforming urban transportation paradigms. Their efforts have resulted in the development and adoption of sustainable mobility practices, contributing to more efficient and eco-friendly urban commuting options.

Psychedelic Drugs Market - Key Insights:

  • As per the insights provided by our research analysts, the global Market for Psychedelic Drugs is poised to experience a robust annual growth rate, with a projected Compound Annual Growth Rate (CAGR) of approximately 14.2% throughout the forecast period spanning from 2023 to 2030.
  • This industry's growth trajectory is underpinned by significant factors, primarily the increasing recognition of the critical need to address mental health challenges on a global scale.
  • Within the realm of drug categorization, the segment dedicated to psilocybin emerged as the dominant player in terms of market share for the year 2022.
  • Furthermore, when considering application segmentation, the category related to the treatment of resistant depression stood out as the frontrunner in 2022.
  • Examining distribution channels, hospitals took the lead in 2022 in terms of market presence.
  • In geographical terms, North America emerged as the primary revenue contributor in the year 2022.

Psychedelic Drugs Market- Segmentation Analysis:

  • The Global Market for Psychedelic Drugs exhibits a comprehensive segmentation structure, incorporating Drug Type, Application, Technology, and Geographical Region as its key categorizations.
  • Within the spectrum of Drug Type classification, the market presents a diverse array of categories, including Ketamine, Gamma Hydroxybutyric Acid (GHB), Lysergic Acid Diethylamide (LSD), Psilocybin, 3,4-MethylEnedioxyMethamphetamine, and various other drug types. Notably, the market's landscape is currently dominated by Psilocybin. This particular compound has been at the forefront of clinical investigations, with studies focusing on its potential efficacy in treating a spectrum of conditions such as addiction, anxiety, depression, and end-of-life distress. The preliminary research findings have unveiled promising outcomes, prompting considerable interest and financial support for the development of treatment modalities based on Psilocybin.

Psychedelic Drugs Market- Competitive Landscape:

Enterprises employ diverse strategies to bring their products to market, utilizing an array of distribution channels such as corporate websites, online retail platforms, brick-and-mortar retailers, distribution partners, and direct-to-consumer models. Product manufacturers engage in competition across multiple fronts, including pricing strategies, product performance, manufacturing techniques, technological innovation, brand reputation, and product availability.

To fortify their market presence and expand their market share, companies employ a range of tactics. These include product portfolio enhancements through new product launches, the expansion of distribution networks, increased investments in research and development, and participation in mergers and acquisitions.

For instance, in October 2022, Numinus Wellness Inc., a mental health care organization dedicated to advancing evidence-based, safe psychedelic-assisted treatments, introduced its Ketamine for Serious and Chronic Medical Illness Program. This innovative initiative is expected to roll out initially in Numinus clinics located in British Columbia, Utah, and Quebec, signifying a progressive approach to addressing medical conditions through novel therapeutic avenues.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PSYCHEDELIC DRUGS MARKET KEY PLAYERS

  • Silo Wellness
  • Revive Therapeutics
  • PsyBio Therapeutics
  • Numinus Wellness
  • Mydecine Innovations Group
  • MindMed
  • MagicMed Industries
  • Field Trip Health
  • Entheon Biomedical
  • Eleusis Ltd.
  • Cybin Inc.
  • Compass Pathways
  • Bright Minds Biosciences
  • Beckley Psytech
  • Atai Life Sciences

GLOBAL PSYCHEDELIC DRUGS MARKET, BY DRUG TYPE

  • Ketamine
  • Gamma Hydroxybutyric Acid (GHB)
  • Lysergic Acid Diethylamide (LSD)
  • Psilocybin
  • 3,4-MethylEnedioxyMethamphetamine
  • Other Drug Types

GLOBAL PSYCHEDELIC DRUGS MARKET, BY APPLICATION

  • Opiate Addiction
  • Treatment-Resistant Depression
  • Narcolepsy
  • Post-traumatic Stress Disorder
  • Panic Disorder
  • Others Applications

GLOBAL PSYCHEDELIC DRUGS MARKET, BY DISTRIBUTION

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Distribution Channel

GLOBAL PSYCHEDELIC DRUGS MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Psychedelic Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Psychedelic Drugs Market Snippet by Drug Type
    • 2.1.2. Psychedelic Drugs Market Snippet by Application
    • 2.1.3. Psychedelic Drugs Market Snippet by Distribution
    • 2.1.4. Psychedelic Drugs Market Snippet by Country
    • 2.1.5. Psychedelic Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Psychedelic Drugs Key Market Trends

  • 3.1. Psychedelic Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Psychedelic Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Psychedelic Drugs Market Opportunities
  • 3.4. Psychedelic Drugs Market Future Trends

4. Psychedelic Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Psychedelic Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Psychedelic Drugs Market Landscape

  • 6.1. Psychedelic Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Psychedelic Drugs Market - By Drug Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Type, 2022 & 2030 (%)
    • 7.1.2. Ketamine
    • 7.1.3. Gamma Hydroxybutyric Acid (GHB)
    • 7.1.4. Lysergic Acid Diethylamide (LSD)
    • 7.1.5. Psilocybin
    • 7.1.6. 3,4-MethylEnedioxyMethamphetamine
    • 7.1.7. Other Drug Types

8. Psychedelic Drugs Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Opiate Addiction
    • 8.1.3. Treatment-Resistant Depression
    • 8.1.4. Narcolepsy
    • 8.1.5. Post-traumatic Stress Disorder
    • 8.1.6. Panic Disorder
    • 8.1.7. Others Applications

9. Psychedelic Drugs Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2022 & 2030 (%)
    • 9.1.2. Retail Pharmacy
    • 9.1.3. Hospital Pharmacy
    • 9.1.4. Online Distribution Channel

10. Psychedelic Drugs Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Psychedelic Drugs Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Psychedelic Drugs Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Psychedelic Drugs Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Psychedelic Drugs Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Psychedelic Drugs Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Psychedelic Drugs Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Silo Wellness
    • 11.2.2. Revive Therapeutics
    • 11.2.3. PsyBio Therapeutics
    • 11.2.4. Numinus Wellness
    • 11.2.5. Mydecine Innovations Group
    • 11.2.6. MindMed
    • 11.2.7. MagicMed Industries
    • 11.2.8. Field Trip Health
    • 11.2.9. Entheon Biomedical
    • 11.2.10. Eleusis Ltd.
    • 11.2.11. Cybin Inc.
    • 11.2.12. Compass Pathways
    • 11.2.13. Bright Minds Biosciences
    • 11.2.14. Beckley Psytech
    • 11.2.15. Atai Life Sciences

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Psychedelic Drugs Market: Drug Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Type
  • TABLE Global Psychedelic Drugs Market, by Drug Type 2018-2030 (USD Million)
  • TABLE Psychedelic Drugs Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Psychedelic Drugs Market, by Application 2018-2030 (USD Million)
  • TABLE Psychedelic Drugs Market: Distribution Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution
  • TABLE Global Psychedelic Drugs Market, by Distribution 2018-2030 (USD Million)
  • TABLE Psychedelic Drugs Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Psychedelic Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America Psychedelic Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Psychedelic Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE North America Psychedelic Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Psychedelic Drugs Market, by Distribution, 2018-2030 (USD Million)
  • TABLE Europe Psychedelic Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Psychedelic Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Europe Psychedelic Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Psychedelic Drugs Market, by Distribution, 2018-2030 (USD Million)
  • TABLE Asia Pacific Psychedelic Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Psychedelic Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Psychedelic Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Psychedelic Drugs Market, by Distribution, 2018-2030 (USD Million)
  • TABLE Latin America Psychedelic Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Psychedelic Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Latin America Psychedelic Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Psychedelic Drugs Market, by Distribution, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Psychedelic Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Psychedelic Drugs Market, by Drug Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Psychedelic Drugs Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Psychedelic Drugs Market, by Distribution, 2018-2030 (USD Million)

List of Figures

  • FIGURE Psychedelic Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Drug Type segment market share analysis, 2022 & 2030
  • FIGURE Drug Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Distribution segment market share analysis, 2022 & 2030
  • FIGURE Distribution segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Psychedelic Drugs Market share and leading players, 2022
  • FIGURE Europe Psychedelic Drugs Market share and leading players, 2022
  • FIGURE Asia Pacific Psychedelic Drugs Market share and leading players, 2022
  • FIGURE Latin America Psychedelic Drugs Market share and leading players, 2022
  • FIGURE Middle East and Africa Psychedelic Drugs Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Psychedelic Drugs Market share analysis by country, 2022
  • FIGURE Germany Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Psychedelic Drugs Market share analysis by country, 2022
  • FIGURE India Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Psychedelic Drugs Market share analysis by country, 2022
  • FIGURE Brazil Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Psychedelic Drugs Market share analysis by country, 2022
  • FIGURE Saudi Arabia Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Psychedelic Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)